Advancing Imaging Operations & Analysis in Alzheimer's Disease Late-Stage Clinical Trials, Upcoming Webinar Hosted by Xtalks

In this free webinar, the featured speakers will provide an overview of imaging biomarkers in Alzheimer's clinical trials. They will discuss the challenges in imaging operations for Phase III Alzheimer's clinical trials, and how they can be overcome by streamlining imaging operations and harnessing AI technology.

TORONTO (PRWEB) October 30, 2020

Phase III clinical trials are required to prove the effectiveness and safety of a drug in a larger population. After decades of research, Alzheimer's disease still has no disease-modifying drug that is approved as many of the drug development programs fail in later-stage phases. Due to the complexity of the disease and challenges associated with large scale later phase studies, Phase III Alzheimer's clinical trials require neuroimaging approaches that successfully blend robust operational infrastructure, effective data management platform and advanced analytics.

This webinar will address practices to optimize the entire operational lifecycle including site qualification, investigator training and radiological reads in Alzheimer's clinical trials.

In view of the large and complex data sets within Phase III trials, this webinar will present the advanced TrialTracker platform for scaling-up processes and systems to manage imaging data, from radiological read workflow to imaging analysis. It will additionally cover the AI-driven LEAP platform used to perform advanced segmentation and volumetric analysis in Alzheimer's trials.

Join Roger Bullock, Chief Medical Officer, Oryzon; Shona Clegg, Senior Project Manager/Portfolio Lead, IXICO; and Richard Joules, Imaging Science Manager, IXICO in a live webinar on Friday, November 13, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Advancing Imaging Operations & Analysis in Alzheimer's Disease Late-Stage Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

For the original version on PRWeb visit: https://www.prweb.com/releases/advancing_imaging_operations_analysis_in_alzheimers_disease_late_stage_clinical_trials_upcoming_webinar_hosted_by_xtalks/prweb17512468.htm